Kayne Anderson Rudnick Investment Management
CLB icon

Kayne Anderson Rudnick Investment Management’s Core Laboratories CLB Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,115
Closed -$56K – 595
2020
Q4 		$56K Sell
2,115
-82
-4% -$1.68K ﹤0.01% 434
2020
Q3 		$34K Hold
2,197
– – ﹤0.01% 432
2020
Q2 		$45K Sell
2,197
-189
-8% -$3.39K ﹤0.01% 405
2020
Q1 		$25K Sell
2,386
-1,529,792
-100% -$42.8M ﹤0.01% 417
2019
Q4 		$57.7M Sell
1,532,178
-66,168
-4% -$2.97M 0.28% 87
2019
Q3 		$74.5M Buy
1,598,346
+33,509
+2% +$1.56M 0.39% 69
2019
Q2 		$81.8M Buy
1,564,837
+10,877
+0.7% +$638K 0.43% 60
2019
Q1 		$107M Buy
1,553,960
+170,124
+12% +$11.4M 0.61% 42
2018
Q4 		$82.6M Sell
1,383,836
-700,915
-34% -$60.5M 0.57% 47
2018
Q3 		$241M Buy
2,084,751
+10,504
+0.5% +$1.19M 1.41% 20
2018
Q2 		$262M Sell
2,074,247
-100,394
-5% -$12.2M 1.68% 14
2018
Q1 		$235M Buy
2,174,641
+154,855
+8% +$17.1M 1.76% 15
2017
Q4 		$221M Sell
2,019,786
-5,571
-0.3% -$556K 1.79% 12
2017
Q3 		$200M Buy
2,025,357
+323,357
+19% +$31.3M 1.8% 12
2017
Q2 		$172M Buy
1,702,000
+22,276
+1% +$2.4M 1.72% 13
2017
Q1 		$194M Buy
1,679,724
+46,010
+3% +$5.35M 2.11% 6
2016
Q4 		$196M Sell
1,633,714
-245,994
-13% -$27.2M 2.34% 3
2016
Q3 		$211M Buy
1,879,708
+389,553
+26% +$44.9M 2.64% 2
2016
Q2 		$185M Buy
1,490,155
+19,231
+1% +$2.32M 2.78% 3
2016
Q1 		$165M Buy
1,470,924
+64,461
+5% +$6.7M 2.69% 2
2015
Q4 		$153M Sell
1,406,463
-319,132
-18% -$36.5M 2.52% 3
2015
Q3 		$172M Buy
1,725,595
+303,272
+21% +$33M 2.92% 2
2015
Q2 		$162M Sell
1,422,323
-12,834
-0.9% -$1.56M 2.52% 4
2015
Q1 		$150M Buy
1,435,157
+859,166
+149% +$91.5M 2.32% 6
2014
Q4 		$69.3M Buy
575,991
+418,495
+266% +$55M 1.15% 23
2014
Q3 		$23.1M Sell
157,496
-3,386
-2% -$523K 0.41% 73
2014
Q2 		$26.9M Buy
160,882
+29,623
+23% +$5.27M 0.46% 60
2014
Q1 		$26M Sell
131,259
-7,745
-6% -$1.46M 0.46% 61
2013
Q4 		$26.5M Sell
139,004
-1,667
-1% -$310K 0.44% 60
2013
Q3 		$23.8M Sell
140,671
-3,769
-3% -$585K 0.45% 58
2013
Q2 		$21.9M Buy
+144,440
New +$20.5M 0.44% 61

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's CLB Position: Q1 2021 in Review

Kayne Anderson Rudnick Investment Management sold out of Core Laboratories (CLB) in Q1 2021, closing a stake of 2,115 shares — an estimated $56K sold.

Kayne Anderson Rudnick Investment Management first reported a position in CLB in Q2 2013 and held it in 31 quarters. The position peaked at $262M in Q2 2018. 183 funds tracked by Wall St. Rank hold CLB as of Q1 2021.

  • Kayne Anderson Rudnick Investment Management reported no remaining Core Laboratories position as of Q1 2021 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 2,115 Core Laboratories shares in Q1 2021, an estimated $56K.
  • Kayne Anderson Rudnick Investment Management first reported a position in Core Laboratories in Q2 2013 and held it in 31 quarters.
  • Kayne Anderson Rudnick Investment Management's Core Laboratories position peaked at $262M in Q2 2018.
  • 183 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2021.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2021, filed 17 May 2021.